UV- Spectrophotometric methods have been developed for estimation of Risagiline mesylate in bulk drug and in pharmaceutical formulation as it is not official in any pharmacopoeia. The linearity was found to be in the concentration range of 2-20μg/ml at 210nm, and 20-200μg/ml at 265nm and 272nm. Amounts of drug estimated from tablet formulation were in good agreement with label claim. The method was validated statistically and by recovery studies. The proposed methods are economical and sensitive for the estimation of Risagiline Mesylate (RM) in bulk and tablet dosage.
Loading....